Panalpina opens a new logistics center in Singapore
Healthcare is among the targeted industries for the multi-use facility
Calling it the company’s largest warehousing investment outside Europe ever, Panalpina has announced the opening of a purpose-built, 25,800 sq. m. (278,000 sq. ft.) facility in Singapore, and bringing the company’s total warehousing in the country to over 100,000 sq. m. (1.1. million sq. ft.). it features a number of cutting-edge technologies, including Internet of Things (IoT) data handling, 3D printing and a variety of other automation systems.
A gimlet-eyed warehouse manager will notice one key feature: the building is six stories high, where most warehouses are single-story. The high cost and scarcity of land in Singapore is a factor in this design; Panalpina will go even one step farther by making the roof capable of storing ocean-borne containers two-high. A press release notes that the building is equipped with air conditioning ductwork, which signals the capability to handle temperature-sensitive life sciences products. However, the company made no mention of following good distribution practices (GDPs) for it, even though it has earlier touted GDP compliance for 70 business locations globally.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.
